Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study's location count was updated to 98 locations, and the Franklin, TN site (Clinical Trials Center of Middle Tennessee) was removed from the list, reflecting a revision of active trial sites as of the May 2026 update.SummaryDifference0.2%

- Check18 days agoChange DetectedPage revision label updated from v3.5.2 to v3.5.3 in the site’s versioning metadata. This indicates a new revision of the page, but it does not alter the study data or content visible to users.SummaryDifference0.0%

- Check25 days agoChange DetectedUpdated language and related resource/location text for Valparaiso, Chile (including regional wording) and refreshed the displayed site/release revision from v3.5.0 to v3.5.2.SummaryDifference0.3%

- Check32 days agoChange DetectedAdded a new study site in Québec, Canada (G1V 4G5) and updated the location entry. The previous listing 'Québec, Quebec, Canada, G1V 4G5' was replaced with 'Québec, Canada, G1V 4G5' to reflect a formatting update.SummaryDifference0.7%

- Check47 days agoChange DetectedRemoved Interstitial lung disease 2 and the Genetic and Rare Diseases Information Center from the Resources section.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision tag updated: added Revision: v3.5.0 and removed Revision: v3.4.3. This metadata change does not modify the study content or presented data.SummaryDifference0.0%

Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.